Dachaigh › Luchd-obrach › Sirtex Medical Inc.
Sirtex Medical Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Sirtex Medical Inc. 5 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 5. Tuarastal meadhanach a chaidh a thabhann: $157,394.
A bheil Sirtex Medical Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Sirtex Medical Inc. 5 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 28 Faoi 2025. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Manager, Financial Planning & Analysis [00050929] | 1 | $100,000 |
| Corporate Development Analyst [00050927] | 1 | $77,000 |
| Medical Science Liaison [00051771] | 1 | $161,914 |
| Vice President, Corporate Strategy (00063346) | 1 | $276,300 |
| Senior Principal Mergers and Acquisitions Analyst (00076930) | 1 | $157,394 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 3 | $100,000 |
| FY2024 | 1 | $276,300 |
| FY2025 | 1 | $157,394 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Financial Managers2
- Operations Research Analysts1
- Medical Scientists, Except Epidemiologists1
- Financial and Investment Analysts1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Senior Principal Mergers and Acquisitions Analyst (00076930) | $157,394–$164,000 Ìre IV | Woburn, MA | 28 Faoi 2025 | 18 Iuch 2025 | Dearbhaichte |
| Vice President, Corporate Strategy (00063346) | $276,300–$370,000 Ìre IV | Woburn, MA | 28 Gearr 2024 | 24 Lùna 2024 | Dearbhaichte |
| Medical Science Liaison [00051771] | $161,914–$211,695 Ìre IV | Buford, GA | 6 Ògmh 2023 | 1 Dàmh 2023 | Dearbhaichte |
| Corporate Development Analyst [00050927] | $77,000 Ìre II | Woburn, MA | 7 Màrt 2023 | 1 Lùna 2023 | Dearbhaichte |
| Manager, Financial Planning & Analysis [00050929] | $100,000 Ìre I | Woburn, MA | 7 Màrt 2023 | 1 Lùna 2023 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).